logo
COVID-19 Pandemic Tied to Accelerated Brain Aging

COVID-19 Pandemic Tied to Accelerated Brain Aging

Medscape23-07-2025
The COVID-19 pandemic may have accelerated brain aging, even among people who avoided becoming infected with SARS-CoV-2, new research suggested.
By comparing longitudinal brain scans from healthy adults, researchers found that the average person's brain appeared to age by nearly 6 months for every year lived during the pandemic.
'What surprised me most was that even people who hadn't had COVID showed significant increases in brain aging rates,' lead author Ali-Reza Mohammadi-Nejad, PhD, University of Nottingham, Nottingham, England, said in a statement.
'It really shows how much the experience of the pandemic itself, everything from isolation to uncertainty, may have affected our brain health,' Mohammadi-Nejad said.
The study was published online on July 22 in Nature Communications .
UK Biobank Data
In addition to the well-documented respiratory and systemic manifestations of SARS-CoV-2 infection, compelling evidence has highlighted the ability of the virus to attack the central nervous system.
Studies have shown high rates of fatigue, depression, posttraumatic stress disorder, and cognitive impairment in COVID-19 survivors. Research has also revealed potential associations between COVID-19, cognitive decline, brain changes, and the molecular signatures of brain aging.
Mohammadi-Nejad and colleagues investigated the pandemic's impact on brain aging using longitudinal brain MRI data from 996 healthy adults participating in the UK Biobank study. Some participants had scans before and after the pandemic (the pandemic group); others, only before the pandemic (control group).
They used advanced imaging and machine learning to estimate each person's 'brain age'— how old their brain appeared to be compared to their actual age. They used brain scans from 15,334 healthy individuals to develop a brain age model.
Results showed that even with initially matched brain age gaps (predicted brain age vs chronological age) and matched for a range of health markers, the pandemic significantly accelerated brain aging.
On average, the pandemic group showed a 5.5-month higher deviation of brain age gap at the second timepoint compared with the control group.
In the pandemic group, increased brain age correlated with lower scores on standard cognitive tests, which might help explain why some people who had COVID-19 have shown impaired cognition, researchers said.
Accelerated brain aging was more pronounced in males and those from deprived socio-demographic backgrounds and these deviations existed regardless of SARS-CoV-2 infection.
'Our findings provide valuable insight into how the COVID-19 pandemic affected brain health, demonstrating that the general pandemic effects alone, without infection, exerted a substantial detrimental effect on brain health, augmented by biosocial factors (age, health, and social inequalities) in a healthy middle-aged to older population,' the investigators note.
'Notably, the extent of accelerated brain aging over a matched pre-pandemic control group, observed in grey and white matter, was similar in both noninfected and infected sub-cohorts,' they noted.
Interpret Cautiously
In a statement from the UK nonprofit Science Media Center several experts weighed in on the results.
'While this is a very carefully conducted analysis, we have to be cautious with interpretation,' said Masud Husain, DPhil, BMBCh, FMedSci, professor of neurology & cognitive neuroscience, University of Oxford, Oxford, England.
'The brain age difference between the two groups (as indexed by brain scanning) was on average only 5 months, and difference in cognitive performance between groups was only on the total time taken to complete one of the tests. Is this really going to make a significant difference in everyday life?' Husain wondered.
'Furthermore, the time between scans was much shorter in the people scanned before and after the pandemic compared to those who had both scans before the pandemic. We therefore don't know if brain aging would have recovered if more time elapsed,' Husain said.
Maxime Taquet, MBBCh, PhD, associate professor, Department of Psychiatry, University of Oxford, said, 'It is important to note that the majority of people showed brain aging at the expected rate.'
Nonetheless, Taquet said the findings raise 'important questions about the long-term neurological impact of the pandemic, whether due to infection itself or the broader psychological and social stress it caused.'
Eugene Duff, PhD, Department of Brain Sciences, Imperial College London, London, England, cautioned that 'as an observational study it is not possible to fully exclude that factors unrelated to the pandemic could contribute to the observed acceleration.
'While the events of the pandemic were exceptional, this work demonstrates the stark effects that the conditions of an individual's life may have on brain and cognitive health, and the value of careful dissection of the myriad of local and global factors contributing to these conditions.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

GE HealthCare Core Operating Margin Faces Tariffs Heat, Raises Annual Outlook
GE HealthCare Core Operating Margin Faces Tariffs Heat, Raises Annual Outlook

Yahoo

timean hour ago

  • Yahoo

GE HealthCare Core Operating Margin Faces Tariffs Heat, Raises Annual Outlook

On Wednesday, GE HealthCare (NYSE:GEHC) reported second-quarter 2025 adjusted earnings of $1.06 per share, which beat the consensus of 92 cents. It was up from $1.00 a year ago. The company reported sales of $5.01 billion, beating the consensus of $4.96 billion. Revenues increased 3% on reported and 2% on an organic basis year-over-year. Revenue growth was driven by strength in the U.S. and Europe, the Middle East, and Africa. Total company book-to-bill was 1.07 times. Total company orders increased 3% organically year-over-year. The net income margin was 9.7% versus 8.9% for the prior year, which was up 80 basis points (bps) with lower tax and interest EBIT margin was 14.6% versus 15.3%, down 80 bps, impacted by tariffs, partially offset by benefits from productivity and volume. View more earnings on GEHC GE HealthCare President and CEO Peter Arduini said, 'We were pleased with solid orders and revenue performance in the second quarter across all segments, reflecting healthy customer investment in capital equipment. We also reported strong earnings performance while leveraging our lean capabilities and demonstrating progress on tariff mitigation...' Guidance GE HealthCare raises its fiscal 2025 adjusted earnings from $3.90-$4.10 per share to $4.43-$4.63 per share compared to the consensus of $4.07. The earnings outlook includes approximately 45 cents of tariff impact. Increased 2025 full-year guidance, reflective of healthy capital investment trends, operational execution, and changes in tariff rates. Adjusted EBIT margin of 15.2%-15.4%, reflecting a decline of 110 bps to 90 bps versus the 2024 Adjusted EBIT margin of 16.3%; this compares to the previous Adjusted EBIT margin guidance of 14.2%-14.4%. The company forecasts Free cash flow of at least $1.4 billion; this compares to previous Free cash flow guidance of at least $1.2 billion. Price Action: GEHC stock is down 7.53% at $71.87 at the last check Wednesday. Read Next:Photo by PixelBiss via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article GE HealthCare Core Operating Margin Faces Tariffs Heat, Raises Annual Outlook originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio

Hidden sleep danger could increase risk of 172 diseases, major study reveals
Hidden sleep danger could increase risk of 172 diseases, major study reveals

Fox News

timean hour ago

  • Fox News

Hidden sleep danger could increase risk of 172 diseases, major study reveals

Experts agree that seven to nine hours of sleep is ideal for most adults — but when it comes to your health, the total number of hours might not be the most important factor. In a major new study led by teams from Peking University and Army Medical University, sleep irregularity has been linked to an increased risk of 172 different diseases. The researchers analyzed nearly seven years of UK Biobank sleep data from 88,461 adults averaging 62 years of age, focusing on multiple traits that included nocturnal sleep duration, sleep onset timing, sleep rhythm and sleep fragmentation, according to a press release. They then compared that data to disease outcomes from the National Health Service, the Cancer Registry and the National Death Index. They found that for 92 diseases — Parkinson's disease and acute kidney failure — 20% of the risk was tied to poor sleep behavior. Forty-two diseases were linked to at least double the risk. Those included age-related frailty, gangrene, and fibrosis and cirrhosis of the liver. Poor sleep traits were linked to 1.5 times the risk of 122 diseases, including type 2 diabetes mellitus, respiratory failure, certain bone fractures and urinary incontinence. Inflammatory pathways were identified as one possible link between irregular sleep and disease. "Some common diseases showed considerable attributable risk, such as Parkinson's disease, pulmonary heart disease, type 2 diabetes mellitus, obesity, thyrotoxicosis (hyperthyroidism) and urinary incontinence," the researchers wrote. The results were published in the journal Health Data Science. "Our findings underscore the overlooked importance of sleep regularity," said Prof. Shengfeng Wang, senior author of the study, in the release. "It's time we broaden our definition of good sleep beyond just duration." "It's time we broaden our definition of good sleep beyond just duration." Ashley Curtis, PhD, assistant professor and director of the Cognition, Aging, Sleep, and Health (CASH) Lab in the College of Nursing at the University of South Florida, was not involved in the research but shared her reaction to the findings. "This study contributes to the growing evidence supporting the critical role sleep plays as a key modifiable risk factor across a range of medical disorders, particularly in mid- to late-life," she told Fox News Digital. "However, this study also emphasizes that how we measure sleep matters in terms of what conclusions we make regarding its impact on health across the lifespan." Curtis highlighted the difference between self-reported sleep patterns versus objective measurements captured by wearable devices. "Better understanding these patterns is important, because it can impact recommendations regarding what aspects of sleep we should be monitoring more closely in terms of assessing the risk of future declines in health," she said. "Additionally, these findings provide insight into the specific physiological sleep-related mechanisms that may be driving comorbid disease trajectories." The researchers noted several major limitations in this research. The most prevalent is that the study is not representative of the nationwide population, as the participants were mainly middle-aged or elderly and therefore more susceptible to certain diseases. The sleep data was also captured at only one single point in time. There is also a chance that external factors or "reverse causation bias" affected the results, they stated. Curtis echoed these limitations, noting that sleep was only measured across one seven-day time period and did not consider variability in sleep patterns over time. "Further, there was a lack of consideration of sleep disorders, such as insomnia or sleep apnea," she told Fox News Digital. "Given that both of these sleep disorders are highly prevalent in aging populations, there is a need for future studies that include a more comprehensive clinical assessment in order to fully elucidate the link between sleep disorder profiles and the risk of other medical comorbidities." For more Health articles, visit The research team plans to conduct future studies to confirm causality and to measure how sleep interventions may impact chronic disease outcomes. The study was supported by the National Key R&D Program of China, the National Natural Science Foundation of China and the Beijing Municipal Health Development Research Fund.

Thousands Of Microplastics Floating In Your Home And Car Are Slowly Damaging Your Lungs: Study
Thousands Of Microplastics Floating In Your Home And Car Are Slowly Damaging Your Lungs: Study

Forbes

time2 hours ago

  • Forbes

Thousands Of Microplastics Floating In Your Home And Car Are Slowly Damaging Your Lungs: Study

While we live in the Plastics Age, and it may no longer be a huge surprise that we are constantly exposed to microplastics, a new study claims that we might be inhaling 100 times more microplastics in our own homes and cars than scientists had previously estimated. To be more specific, human beings might be inhaling around 68,000 microplastic particles that are not visible to the naked eye inside their homes and cars. Lead author Nadiia Yakovenko and team from the Université de Toulouse in France had collected 16 air samples from their apartments and cars. The researchers then measured the concentrations of microplastics present in each air sample, as well as the size of the microplastics. They particularly focused on microplastics that are less than 10 micrometers and more likely to penetrate deep into lung tissues compared to fine particulate matter that is bigger than 10 micrometers or visible to the naked eye. Studies have found that inhaled particles larger than 10 µm are more likely to get collected in the upper respiratory tract and automatically get cleared out of your airways. However, your respiratory system cannot filter out fine particulate matter smaller than 10 micrometers, and so, it can penetrate deeper into the lungs. Microplastics smaller than 10 micrometers are of particular concern because they could release toxic additives into your cardiovascular system along with other environmental pollutants that it might have absorbed while floating around in the air. Multiple studies have shown that microplastics could potentially disrupt your body's normal endocrine functions and might even increase the risk of various diseases like cancer. "Microplastic is a ubiquitous pollutant resulting from the global extensive human use of plastic materials since 1950 and the mismanagement of plastic waste. The term 'microplastic' refers to plastic particles between 1 µm and 5mm in size that come in a variety of shapes and polymer compositions," the authors explained in their study that was published in PLoS One on July 30. "Human inhalation of fine particulate microplastic 1–10 µm that penetrate deep lung tissue may contribute to causing lung tissue damage, inflammation, and associated diseases." "Over the past decade, microplastics have been detected in outdoor atmospheric aerosols and deposition, in various parts of the world, from urban and highly industrialized areas to remote mountainous regions, the marine boundary layer, and indoor environments. The ubiquitous presence of microplastics in the atmosphere raises many concerns about whether, and to what extent, we are inhaling microplastics from outdoor and indoor air, with the latter likely playing the most significant role in human exposure to microplastics through inhalation," they added. 'Recent studies have shown that the concentration of indoor suspended MPs is eight times higher than outdoors, and the concentration of indoor deposited microplastic dust is 30 times higher than outdoors. Given that people in developed nations spend approximately 90% of their time indoors, including 5% in cars, the potential for inhalation exposure to MPs in indoor environments is significantly higher and warrants attention.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store